State-of-the-Art PaperUse of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases
Under an Elsevier user license
open archive
Key Words
cardiovascular agents
complementary therapies
drug approval
herbal medicine
herb–drug interaction
Abbreviations and Acronyms
BPH
benign prostatic hypertrophy
CAM
complementary and alternative medicine
CHF
congestive heart failure
FDA
U.S. Food and Drug Administration
Cited by (0)
Dr. Tachjian is a visiting physician at the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Dr. Jahangir is supported in part by grants from the National Institute on Aging(AG21201); the National Heart, Lung, and Blood Institute(HL089542); the Mayo Clinic Marriott Mitochondrial Medicine Award; and the Angel and Paul Harvey Cardiovascular Research Endowment.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.